Innate Pharma (IPHA) Change in Intangibles (2019 - 2023)
Historic Change in Intangibles for Innate Pharma (IPHA) over the last 5 years, with Q4 2023 value amounting to -$2.2 million.
- Innate Pharma's Change in Intangibles fell 25931.43% to -$2.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$15.6 million, marking a year-over-year increase of 8154.36%. This contributed to the annual value of -$71.8 million for FY2019, which is 1083465.54% down from last year.
- Latest data reveals that Innate Pharma reported Change in Intangibles of -$2.2 million as of Q4 2023, which was down 25931.43% from -$598885.2 recorded in Q4 2022.
- Over the past 5 years, Innate Pharma's Change in Intangibles peaked at -$458732.4 during Q4 2021, and registered a low of -$71.0 million during Q4 2019.
- For the 5-year period, Innate Pharma's Change in Intangibles averaged around -$17.3 million, with its median value being -$2.2 million (2023).
- Per our database at Business Quant, Innate Pharma's Change in Intangibles soared by 9629.16% in 2021 and then crashed by 25931.43% in 2023.
- Innate Pharma's Change in Intangibles (Quarter) stood at -$71.0 million in 2019, then soared by 82.57% to -$12.4 million in 2020, then soared by 96.29% to -$458732.4 in 2021, then plummeted by 30.55% to -$598885.2 in 2022, then plummeted by 259.31% to -$2.2 million in 2023.
- Its Change in Intangibles was -$2.2 million in Q4 2023, compared to -$598885.2 in Q4 2022 and -$458732.4 in Q4 2021.